SCHEMBL11941019

SCHEMBL11941019

C[C@@H]1CN(c2cnc(N)cn2)C[C@H](C)O1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.48
MTOR P42345 3/20 0.48
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 1/20 0.42
MAP3K12 Q12852 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SOS1 Q07889 3/20 0.40
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
LRRK2 Q5S007 2/20 0.39
HTT P42858 1/20 0.39
TLR9 Q9NR96 1/20 0.38
TLR8 Q9NR97 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18436518 0.82 KMT2A (0.47) PIK3CAKMT2AKDM4EALDH1A1GAA
SCHEMBL18436325 0.82 KMT2A (0.47) PIK3CAKMT2AKDM4EALDH1A1GAA
SCHEMBL20034308 0.80 KMT2A (0.43) PIK3CAMTORKMT2AKDM4EALDH1A1
SCHEMBL19012666 0.78 KMT2A (0.44) KMT2AKDM4EALDH1A1GAAMAP3K12
SCHEMBL18282384 0.78 KMT2A (0.51) PIK3CAMTORKMT2AKDM4EALDH1A1
SCHEMBL19012693 0.78 KMT2A (0.44) KMT2AKDM4EALDH1A1GAAMAP3K12
SCHEMBL24609881 0.78 KMT2A (0.44) PIK3CAMTORKMT2AKDM4EALDH1A1
SCHEMBL67060 0.78 KMT2A (0.51) PIK3CAMTORKMT2AKDM4EALDH1A1
SCHEMBL30396461 0.78 KMT2A (0.44) PIK3CAMTORKMT2AKDM4EALDH1A1
SCHEMBL22169616 0.78 KMT2A (0.44) PIK3CAMTORKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227618-B2 Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof SHIONOGI & CO., LTD. (JP) 2012-07-24 US disclosed
US-20100273841-A1 AMINE-DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF SHIONOGI & CO., LTD. (JP) 2010-10-28 US disclosed
US-20100063027-A1 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity SHIONOGI & CO., LTD. (JP) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063027-A1 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity NPY5R, NPY1R, NPY2R PIK3CA 4280/4885MTOR 3457/4885KMT2A 2031/4885
US-20100273841-A1 AMINE-DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF NPY5R, NPY1R, NPY2R PIK3CA 3980/4885MTOR 2665/4885KMT2A 2200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.